AI in Oncology Market Analysis

AI in Oncology Market Analysis

To get key market trends

  Download Free Sample

Based on component, the market is bifurcated into software solutions, hardware, and services. The hardware segment held the market size of USD 600.4 million in 2023.

• Advanced hardware such as high-performance computing (HPC) systems, and graphics processing units (GPUs) can process large datasets and complex algorithms at accelerated speeds. This enables AI models to analyze medical images, genomic data, and clinical records rapidly, facilitating timely diagnosis, and treatment planning.

   

• Further, hardware accelerators such as tensor processing units (TPUs), and field-programmable gate arrays (FPGAs) expedite the training of AI models by reducing processing times and optimizing resource utilization.

   

• Moreover, advances in hardware technology including the development of energy-efficient processors, and cloud-based computing services have led to cost-effective solutions for AI deployment in oncology, thereby propelling the growth of the market.

Based on cancer type, the AI in oncology market is segmented into breast cancer, lung cancer, prostate cancer, colorectal cancer, brain tumor, and other cancer types. The breast cancer segment is expected to reach a market size of USD 5 billion by the end of 2032.

• AI is revolutionizing breast cancer care by meticulously analyzing mammograms and other imaging scans, ensuring exceptional accuracy in detecting potential abnormalities and signs of cancer. This transformative technology not only aids in early detection but also plays a pivotal role in guiding breast cancer therapeutics, thereby significantly improving patient outcomes.

   

• For instance, according to the World Health Organization (WHO) in 2020, breast cancer accounted for approximately 2.3 million cases and resulted in 685,000 deaths worldwide.

   

• Further, AI-driven predictive models analyze clinical and genomic data to predict individual patient outcomes and treatment responses. This enables oncologists to develop personalized treatment plans tailored to the specific characteristics of each patient's breast cancer, optimizing therapeutic efficacy, and minimizing adverse effects.

   

Based on application, the AI in oncology market is segmented into diagnostics, radiation therapy, research and development, chemotherapy, and immunotherapy. The diagnostics segment held a market size of USD 341.4 million in 2023.

• In AI oncology, diagnostics benefit significantly from advanced algorithms and technologies. AI systems can analyze complex medical data including imaging scans, genetic profiles, and patient records with remarkable accuracy and efficiency.

   

• Further, these excel at detecting tumors in their earliest stages by analyzing various medical imaging scans including mammograms, CT scanner, and MRI systems. Through this analysis, AI algorithms can identify even the smallest lesions or abnormalities that might signal cancer.

   

• Additionally, AI driven diagnostics facilitate large-scale analysis of medical data, accelerating research efforts, and innovation in oncology. By identifying new cancer biomarkers, therapeutic targets, and treatment modalities, AI technologies contribute to the development of novel cancer diagnostics and therapies.

Based on end-use, the AI in oncology market is segmented into hospitals, diagnostics centres, specialty clinics, and other end-users. The hospitals segment expected reach a market size of USD 7.6 billion by 2032.

• AI algorithms can analyse medical data including imaging scans, and pathology reports with remarkable precision. This leads to more accurate and reliable cancer diagnosis, reducing the likelihood of misdiagnosis, and ensuring patients receive appropriate treatment.

   

• Further, these tools can analyze medical data rapidly, enabling quicker interpretation of imaging scans, and test results. This accelerates the diagnostic process allowing healthcare providers to initiate treatment plans promptly and improve patient outcomes.

   

• Moreover, AI in oncology facilitates large-scale analysis of clinical data, accelerating research efforts, and driving innovation in cancer care. Thereby, escalating the growth of the market.

North America AI in oncology market accounted for USD 758.1 million revenue in 2023 and is predicted to witness substantial market growth.

• The region boasts advanced healthcare infrastructure, including state-of-the-art hospitals, research institutions, and medical facilities. This infrastructure supports the adoption and implementation of AI technologies in oncology allowing for seamless integration into existing healthcare systems.

   

• The increasing incidence of cancer has emerged as a significant concern. As per the Centers for Disease Control and Prevention (CDC), in 2020, there were 1,603,844 cases of cancer, resulting in 602,347 deaths in U.S.

   

• Further, North America is a hub for technological innovation with numerous companies and research institutions at the forefront of AI development in healthcare. This culture of innovation fosters the rapid advancement and adoption of AI technologies in oncology.